JP2016509061A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509061A5
JP2016509061A5 JP2015558986A JP2015558986A JP2016509061A5 JP 2016509061 A5 JP2016509061 A5 JP 2016509061A5 JP 2015558986 A JP2015558986 A JP 2015558986A JP 2015558986 A JP2015558986 A JP 2015558986A JP 2016509061 A5 JP2016509061 A5 JP 2016509061A5
Authority
JP
Japan
Prior art keywords
agent
antagonist
cns
receptor
aqp4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015558986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509061A (ja
JP6382232B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/017606 external-priority patent/WO2014130777A1/en
Publication of JP2016509061A publication Critical patent/JP2016509061A/ja
Publication of JP2016509061A5 publication Critical patent/JP2016509061A5/ja
Application granted granted Critical
Publication of JP6382232B2 publication Critical patent/JP6382232B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015558986A 2013-02-21 2014-02-21 脳全体の傍血管経路を老廃物のクリアランス機能について評価するための方法、およびそれに基づいて神経変性障害を治療するための方法 Active JP6382232B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361767546P 2013-02-21 2013-02-21
US61/767,546 2013-02-21
US201361862321P 2013-08-05 2013-08-05
US61/862,321 2013-08-05
US201461942447P 2014-02-20 2014-02-20
US61/942,447 2014-02-20
PCT/US2014/017606 WO2014130777A1 (en) 2013-02-21 2014-02-21 Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon

Publications (3)

Publication Number Publication Date
JP2016509061A JP2016509061A (ja) 2016-03-24
JP2016509061A5 true JP2016509061A5 (enExample) 2017-06-15
JP6382232B2 JP6382232B2 (ja) 2018-08-29

Family

ID=51391839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015558986A Active JP6382232B2 (ja) 2013-02-21 2014-02-21 脳全体の傍血管経路を老廃物のクリアランス機能について評価するための方法、およびそれに基づいて神経変性障害を治療するための方法

Country Status (5)

Country Link
US (1) US9901650B2 (enExample)
EP (1) EP2964270A4 (enExample)
JP (1) JP6382232B2 (enExample)
CN (1) CN105228652A (enExample)
WO (1) WO2014130777A1 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160066798A1 (en) * 2013-04-09 2016-03-10 University Of Washington Through Its Center For Commercialization Methods and Systems for Determining Hemodynamic Properties of a Tissue
EP3081263B1 (en) * 2015-04-17 2020-02-12 P&X Medical NV Compositions and tools for treating glaucoma
US10874798B2 (en) 2014-10-15 2020-12-29 P&X Medical Nv Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor
US9681821B2 (en) 2015-02-19 2017-06-20 Synaptive Medical (Barbados) Inc. Methods for measuring global glymphatic flow using magnetic resonance imaging
EP3325992B1 (en) 2015-07-24 2026-01-28 Northeastern University Quantitative magnetic resonance imaging of the vasculature
WO2017223092A1 (en) * 2016-06-21 2017-12-28 New York University System and method for in vivo detection of cerebrospinal fluid egress
US20190282792A1 (en) * 2016-07-20 2019-09-19 P&X Medical Nv Compounds for use in methods for treating glaucoma and retinal diseases
USD867397S1 (en) * 2016-07-22 2019-11-19 Koninklijke Philips N.V. Display screen with icon
US10342221B2 (en) * 2016-08-19 2019-07-09 University Of Southern California Generation of an inducible pericyte-specific CRE mouse model
US11426577B2 (en) * 2016-08-26 2022-08-30 Wisconsin Alumni Research Foundation Neuromodulation to modulate glymphatic clearance
SG10202107367SA (en) 2016-12-31 2021-08-30 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
CN106887025B (zh) 2017-01-16 2019-06-11 浙江大学 一种基于栈式自编码器的混合示踪剂动态pet浓度分布图像重建的方法
CN106801055A (zh) * 2017-01-23 2017-06-06 徐辉 一种检测aqp‑4自身抗体的芯片、制备方法及其应用
WO2018174721A2 (en) 2017-03-23 2018-09-27 Brainwidesolutions As Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human
CN108129563B (zh) * 2018-01-12 2020-12-01 沈阳眼产业技术研究院有限公司 一种抗aqp4的小分子抗体及其应用
KR102080023B1 (ko) * 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
WO2019157119A1 (en) * 2018-02-07 2019-08-15 University Of Cincinnati System and method for detecting small blood-tissue barrier disruption
EP3540494B1 (en) * 2018-03-16 2022-11-23 Leica Instruments (Singapore) Pte. Ltd. Augmented reality surgical microscope and microscopy method
WO2019200342A1 (en) * 2018-04-12 2019-10-17 The J. David Gladstone Institutes Methods for treating apoe4/4-associated disorders
JP6945493B2 (ja) * 2018-05-09 2021-10-06 富士フイルム株式会社 医用画像処理装置、方法およびプログラム
ES3004544T3 (en) 2018-06-27 2025-03-12 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
WO2020014394A1 (en) * 2018-07-10 2020-01-16 The Board Of Trustees Of The Leland Stanford Junior University Intranasal vasopressin treatment of social deficits in autism
US20210298662A1 (en) * 2018-07-27 2021-09-30 Northeastern University Diagnosis of Dementia by Vascular Magnetic Resonance Imaging
WO2020040438A1 (ko) 2018-08-23 2020-02-27 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 우수한 방출특성을 갖는 약제학적 제제
US20220280423A1 (en) * 2018-10-04 2022-09-08 University Of Rochester Glymphatic delivery by manipulating plasma osmolarity
WO2020072357A1 (en) 2018-10-04 2020-04-09 University Of Rochester Improvement of glymphatic delivery by manipulating plasma osmolarity
WO2020142696A1 (en) 2019-01-03 2020-07-09 Northeastern University Quantitative measurement of disruptions in the blood brain barrier
KR102307479B1 (ko) * 2019-02-12 2021-09-30 단국대학교 천안캠퍼스 산학협력단 신경전달물질 기반의 뇌 지도 작성 방법 및 뇌 지도를 이용하는 용도
WO2020166979A2 (ko) * 2019-02-12 2020-08-20 주식회사 뉴로비스 신경전달물질 기반의 뇌 지도 작성 방법 및 뇌 지도를 이용하는 용도
WO2020185758A1 (en) 2019-03-12 2020-09-17 Bayer Healthcare Llc Systems and methods for assessing a likelihood of cteph and identifying characteristics indicative thereof
US12144583B2 (en) 2019-03-21 2024-11-19 Synaptec Network, Inc. Diffusion tensor MR to monitor glymphatic system
CN110192859B (zh) * 2019-05-05 2020-05-19 兰月 一种磁共振测量人脑类淋巴通路清除效率的方法
CN110123324B (zh) * 2019-05-28 2020-05-12 浙江大学 一种婴儿大脑t1加权磁共振成像优化方法
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CA3154689A1 (en) 2019-09-18 2021-03-25 Bayer Aktiengesellschaft System, method, and computer program product for predicting, anticipating, and/or assessing tissue characteristics
WO2021052850A1 (de) 2019-09-18 2021-03-25 Bayer Aktiengesellschaft Erzeugung von mrt-aufnahmen der leber
JP7542060B2 (ja) 2019-09-18 2024-08-29 バイエル、アクチエンゲゼルシャフト 教師あり学習によって訓練された予測モデルによるmri画像の予測
US20230120273A1 (en) * 2019-10-11 2023-04-20 Bayer Aktiengesellschaft Acceleration of mri examinations
US11908131B2 (en) * 2020-02-14 2024-02-20 University Of Southern California Mapping brain perivascular spaces
EP4128261A1 (de) 2020-04-03 2023-02-08 Bayer Aktiengesellschaft Erzeugen von radiologischen aufnahmen
US11559626B2 (en) 2020-04-08 2023-01-24 Medtronic, Inc. Means to treat Alzheimer's disease via flushing of brain parenchyma
EP4277524A4 (en) * 2021-01-13 2025-06-04 Duke University Compositions for and methods of improving fluid flux in the brain
TWI780771B (zh) * 2021-06-15 2022-10-11 臺北醫學大學 腦影像神經異常預測系統及其運作方法
CN113781547B (zh) * 2021-08-05 2024-05-31 东软医疗系统股份有限公司 头部对称轴识别方法及装置、存储介质、计算机设备
US20240350106A1 (en) * 2021-08-17 2024-10-24 University Of Virginia Patent Foundation Systems, methods, and computer readable media for parametric fdg pet quantification, segmentation and classification of abnormalities
EP4401622A4 (en) * 2021-09-14 2025-07-09 Applied Cognition Inc NON-INVASIVE ASSESSMENT OF GLYMPHATIC FLOW AND NEURODEGENERATION FROM A WEARABLE DEVICE
US20250235554A1 (en) * 2021-10-25 2025-07-24 Novartis Ag Methods for improving adeno-associated virus (aav) delivery
US20250031967A1 (en) * 2021-12-01 2025-01-30 Kennedy Krieger Institute F.M. Kirby Research Center Quantification of fluid-tissue exchange using phase alternate labeling with null recovery mri
CN114904066A (zh) * 2022-04-21 2022-08-16 安徽省立医院(中国科学技术大学附属第一医院) 一种具有注射和测压功能的大鼠脑脊液计量收集装置
US12004874B2 (en) * 2022-10-24 2024-06-11 Applied Cognition, Inc. Wearable device and method for non-invasive assessment of glymphatic flow
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
AU2024220563A1 (en) 2023-02-16 2025-08-14 University Of Rochester Improving glymphatic-lymphatic efflux
CN121729176A (zh) * 2023-04-07 2026-03-24 哈佛学院院长及董事 磁共振成像校准系统和方法
US20240354936A1 (en) * 2023-04-19 2024-10-24 Wisconsin Alumni Research Foundation Automated CT Contrast Detection
US20250000468A1 (en) * 2023-06-30 2025-01-02 Kaunas University Of Technology Method and apparatus for early warning of cerebral vasospasm after subarachnoid hemorrhage
CN119303118A (zh) * 2024-12-16 2025-01-14 中南大学湘雅医院 胶质淋巴系统的相关产品在制备诊断或治疗脓毒症脑病产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689085B1 (en) 1996-07-11 2004-02-10 Eunoe, Inc. Method and apparatus for treating adult-onset dementia of the Alzheimer's type
US6321105B1 (en) * 1998-04-08 2001-11-20 Bracco S.P.A. Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life
EP1786463A4 (en) * 2004-03-26 2009-05-20 Human Genome Sciences Inc ANTIBODY AGAINST NOGO RECEPTOR
US7809424B2 (en) * 2005-11-10 2010-10-05 The Board Of Trustees Of The Leland Stanford Junior University Method of off-resonance detection using complementary MR contrast agents
JP5607543B2 (ja) * 2008-02-01 2014-10-15 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 治療に必要な軽度認知障害患者の特定方法とかかる患者の治療剤
US20110183904A1 (en) * 2008-04-10 2011-07-28 The Children's Mercy Hospital Methods and compositions for altering behavior associated with autism spectrum disorder
US8965071B2 (en) 2008-05-30 2015-02-24 Emory University Assessing tumor response to therapy
BRPI0919564A2 (pt) * 2008-10-22 2019-09-24 Genentech, Inc modulação da degeneração do axônio
US8580230B2 (en) * 2009-02-23 2013-11-12 Kent State University Materials and methods for MRI contrast agents and drug delivery
CN102811716B (zh) * 2010-01-15 2017-08-25 国立健康与医学研究所 用于治疗孤独症的化合物

Similar Documents

Publication Publication Date Title
Qadri et al. Kinin B1 receptors as a therapeutic target for inflammation
Kudarha et al. Albumin based versatile multifunctional nanocarriers for cancer therapy: Fabrication, surface modification, multimodal therapeutics and imaging approaches
Yu et al. Developing therapeutic antibodies for neurodegenerative disease
Lochhead et al. Intranasal delivery of biologics to the central nervous system
Lee et al. Effect of a selective mas receptor agonist in cerebral ischemia in vitro and in vivo
MX340112B (es) Composicion que comprende un agonista de receptor de serotonina y una dicetopiperazina para el tratamiento de migrañas.
JP2016528301A5 (enExample)
Yoon et al. Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
Zhang et al. Peripheral interventions enhancing brain glutamate homeostasis relieve amyloid β-and TNFα-mediated synaptic plasticity disruption in the rat hippocampus
EA200802350A3 (ru) Система доставки лекарств
JP2014513065A5 (enExample)
JP2022508609A5 (enExample)
US20180256756A1 (en) Method of transporting an agent across blood-brain, blood-cochlear or blood-cerebrospinal fluid barrier
RU2020114744A (ru) Способы и композиции для эффективной доставки через множество биобарьеров
JP2015534990A5 (enExample)
JP2014534229A5 (enExample)
Muhammad et al. Exosomes as delivery systems for targeted tumour therapy: a systematic review and meta-analysis of in vitro studies
Yamamoto et al. Rapid progression of rhabdoid components of a composite high-grade glioma and rhabdoid tumor in the occipital lobe of an adult
CN106535924A (zh) 阿尔茨海默病(ad)的治疗和预防
JP2020512338A5 (enExample)
Tsuji et al. Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan
KR102506460B1 (ko) 알츠하이머병(ad)의 치료 및 예방
FI3909568T3 (fi) Profylaktinen tai terapeuttinen lääke neurodegeneratiivisiin tauteihin
EP3746065A1 (en) Intratumoral delivery of bortezomib
Dixon et al. Editorial overview: Musculoskeletal: New therapeutic targets and delivery systems